By clicking "Allow All" you agree to the storing of cookies on your device to enhance site navigation,
analyse site usage and support us in providing free open access scientific content.
From bespoke pharmaceutical forecasting models and innovative software to interactive training and resources, we have the solution to your forecasting needs.
At J+D we work alongside Pharmaceutical Forecasters, Analysts, Business Insights Managers and Marketing Departments to create solutions that meet the needs of both individuals and pharmaceutical companies. We balance market complexity with easy to use yet innovative technology, underpinned with the best pharmaceutical forecasting principles.
J+D understand the complex challenges within both global and local forecasting, allowing us to apply these to our solutions.
FC365 - Solves all of your challenges in one complete forecasting system. Powered by trusted Microsoft technology, FC365 fully integrates with your business, encouraging seamless collaboration and instant insights.
FC+ - A suite of innovative software supporting independent and confident forecasting. Created specifically for Epidemiology, Sales and Oncology based forecast models, these Excel add-ins will help you create the forecast you want, your way.
Model Build - With decades of experience building pharmaceutical models, J+D are the experts in bespoke model build, no matter how complex. With unique Aurora technology at the core, model build which took weeks is now achievable in days.
Training - Our passion for forecasting has been injected into our in-depth pharma forecasting training courses. Either face to face or online, our training is interactive and enjoyable for all abilities.
EpiCube - An epidemiology database for multiple therapy areas (inc. Oncology), multiple diseases, attributes, countries, age groups and genders. Easy to manage, aligned to pharmaceutical forecasting structures and offering unrivalled analytical capability.
With our knowledge, experience and passion for innovation, we aim to inspire confidence in pharmaceutical investment decisions allowing us to shape the market alongside our clients.